TD Asset Management Inc Has $14.89 Million Stock Position in Masimo Corporation $MASI

TD Asset Management Inc grew its position in Masimo Corporation (NASDAQ:MASIFree Report) by 6.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 114,514 shares of the medical equipment provider’s stock after buying an additional 6,656 shares during the period. TD Asset Management Inc owned approximately 0.21% of Masimo worth $14,894,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the period. Clearstead Advisors LLC boosted its stake in Masimo by 18.4% in the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73 shares during the period. Hantz Financial Services Inc. boosted its stake in Masimo by 12.9% in the 4th quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 75 shares during the period. Assetmark Inc. boosted its stake in Masimo by 5.5% in the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock worth $241,000 after purchasing an additional 97 shares during the period. Finally, Orion Porfolio Solutions LLC boosted its stake in Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after purchasing an additional 104 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on MASI. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research note on Tuesday, February 17th. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Finally, Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $180.40.

View Our Latest Report on MASI

Masimo Stock Up 0.6%

Shares of MASI stock opened at $179.94 on Tuesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. The firm’s 50-day moving average is $178.51 and its 200-day moving average is $159.66. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.81 and a beta of 1.11. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.97.

Masimo Company Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Read More

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.